2020年撒哈拉以南非洲地区失明和视力障碍患病率:规模和时间趋势系统评价与元分析。

IF 1.7 4区 医学 Q3 OPHTHALMOLOGY
Vision Loss Expert Group Of The Global Burden Of Disease Study, The Gbd Blindness And Vision Impairment Collaborators
{"title":"2020年撒哈拉以南非洲地区失明和视力障碍患病率:规模和时间趋势系统评价与元分析。","authors":"Vision Loss Expert Group Of The Global Burden Of Disease Study, The Gbd Blindness And Vision Impairment Collaborators","doi":"10.1080/09286586.2025.2474654","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To assess burden of blindness and visual impairment (VI) in Sub-Saharan Africa (SSA) as of 2020, the planned end point of the Vision 2020 program.</p><p><strong>Methods: </strong>A systematic review and meta-analysis assessed burden, in the better eye, of blindness (presenting distance visual acuity, VA < 3/60), moderate and severe vision impairment (MSVI; VA < 6/18 but ≥ 3/60) and mild vision impairment (VA < 6/12 and ≥ 6/18); and also functional presbyopia (<N6 or N8 in the presence of ≥ 6/12 best-corrected distance visual acuity) in SSA.</p><p><strong>Results: </strong>In 2020, an estimated 5,083,000 people (95%Uncertainty Interval, UI, 4,474,000-5,696,000) in SSA were bilaterally blind; 20442,000 more (95%UI 18,568,000-22,430,000) had MSVI. The age-standardized prevalence of blindness in SSA is the highest for any GBD super-region, nearly double the world average (0.99%, 95%UI, 0.85-1.12; vs 0.52%, 95% UI, 0.46-0.59 respectively). The Western (4.15%) and Eastern (3.79%) SSA sub-regions had the highest age-standardized prevalence of blindness for the 50+ age group amongst SSA sub-regions. Improvement in age-specific prevalence since 2000 was less than the Vision 2020 target (-25%) for all subcategories of VI; improvement in blindness was the only category close to the goal (about 80-100% of goal across SSA sub-regions).</p><p><strong>Conclusions: </strong>The SSA age-specific prevalence of VI has generally improved since 2000, especially for blindness. However, the number of VI cases has increased with population growth and aging, and Vision 2020 targets were not met. Because most causes of VI require individual-level clinical care, large increases in training and eye care delivery systems development/financing are critical areas of focus.</p>","PeriodicalId":19607,"journal":{"name":"Ophthalmic epidemiology","volume":" ","pages":"1-11"},"PeriodicalIF":1.7000,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence of Blindness and Visual Impairment in Sub-Saharan Africa in 2020: Magnitude and Temporal Trends. Systematic Review and Meta-Analysis.\",\"authors\":\"Vision Loss Expert Group Of The Global Burden Of Disease Study, The Gbd Blindness And Vision Impairment Collaborators\",\"doi\":\"10.1080/09286586.2025.2474654\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To assess burden of blindness and visual impairment (VI) in Sub-Saharan Africa (SSA) as of 2020, the planned end point of the Vision 2020 program.</p><p><strong>Methods: </strong>A systematic review and meta-analysis assessed burden, in the better eye, of blindness (presenting distance visual acuity, VA < 3/60), moderate and severe vision impairment (MSVI; VA < 6/18 but ≥ 3/60) and mild vision impairment (VA < 6/12 and ≥ 6/18); and also functional presbyopia (<N6 or N8 in the presence of ≥ 6/12 best-corrected distance visual acuity) in SSA.</p><p><strong>Results: </strong>In 2020, an estimated 5,083,000 people (95%Uncertainty Interval, UI, 4,474,000-5,696,000) in SSA were bilaterally blind; 20442,000 more (95%UI 18,568,000-22,430,000) had MSVI. The age-standardized prevalence of blindness in SSA is the highest for any GBD super-region, nearly double the world average (0.99%, 95%UI, 0.85-1.12; vs 0.52%, 95% UI, 0.46-0.59 respectively). The Western (4.15%) and Eastern (3.79%) SSA sub-regions had the highest age-standardized prevalence of blindness for the 50+ age group amongst SSA sub-regions. Improvement in age-specific prevalence since 2000 was less than the Vision 2020 target (-25%) for all subcategories of VI; improvement in blindness was the only category close to the goal (about 80-100% of goal across SSA sub-regions).</p><p><strong>Conclusions: </strong>The SSA age-specific prevalence of VI has generally improved since 2000, especially for blindness. However, the number of VI cases has increased with population growth and aging, and Vision 2020 targets were not met. Because most causes of VI require individual-level clinical care, large increases in training and eye care delivery systems development/financing are critical areas of focus.</p>\",\"PeriodicalId\":19607,\"journal\":{\"name\":\"Ophthalmic epidemiology\",\"volume\":\" \",\"pages\":\"1-11\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-03-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ophthalmic epidemiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/09286586.2025.2474654\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmic epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09286586.2025.2474654","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:评估撒哈拉以南非洲地区(SSA)截至2020年的失明和视力障碍(VI)负担,2020年是“愿景2020”计划的终点。方法:一项系统综述和荟萃分析评估了较好眼失明的负担(呈现距离视力,VA)。结果:2020年,估计有5,083,000人(95%不确定性区间,UI, 4,474,000-5,696,000)在SSA中双侧失明;另有20442,000人(95%,18568,000 -22,430,000人)患有MSVI。SSA的年龄标准化失明患病率是所有GBD超级区域中最高的,几乎是世界平均水平的两倍(0.99%,95%UI, 0.85-1.12;vs 0.52%, 95% UI, 0.46-0.59)。西部(4.15%)和东部(3.79%)SSA次区域中50岁以上年龄组失明的年龄标准化患病率最高。自2000年以来,针对特定年龄人群的患病率的改善低于2020年愿景的目标(-25%);失明的改善是唯一接近目标的类别(在SSA次区域中约为目标的80-100%)。结论:自2000年以来,SSA年龄特异性VI患病率普遍改善,特别是失明。然而,随着人口增长和老龄化,VI病例数量增加,2020年愿景目标没有实现。由于大多数VI病因需要个人层面的临床护理,因此培训和眼科护理提供系统开发/融资的大幅增加是关键的重点领域。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Prevalence of Blindness and Visual Impairment in Sub-Saharan Africa in 2020: Magnitude and Temporal Trends. Systematic Review and Meta-Analysis.

Purpose: To assess burden of blindness and visual impairment (VI) in Sub-Saharan Africa (SSA) as of 2020, the planned end point of the Vision 2020 program.

Methods: A systematic review and meta-analysis assessed burden, in the better eye, of blindness (presenting distance visual acuity, VA < 3/60), moderate and severe vision impairment (MSVI; VA < 6/18 but ≥ 3/60) and mild vision impairment (VA < 6/12 and ≥ 6/18); and also functional presbyopia (

Results: In 2020, an estimated 5,083,000 people (95%Uncertainty Interval, UI, 4,474,000-5,696,000) in SSA were bilaterally blind; 20442,000 more (95%UI 18,568,000-22,430,000) had MSVI. The age-standardized prevalence of blindness in SSA is the highest for any GBD super-region, nearly double the world average (0.99%, 95%UI, 0.85-1.12; vs 0.52%, 95% UI, 0.46-0.59 respectively). The Western (4.15%) and Eastern (3.79%) SSA sub-regions had the highest age-standardized prevalence of blindness for the 50+ age group amongst SSA sub-regions. Improvement in age-specific prevalence since 2000 was less than the Vision 2020 target (-25%) for all subcategories of VI; improvement in blindness was the only category close to the goal (about 80-100% of goal across SSA sub-regions).

Conclusions: The SSA age-specific prevalence of VI has generally improved since 2000, especially for blindness. However, the number of VI cases has increased with population growth and aging, and Vision 2020 targets were not met. Because most causes of VI require individual-level clinical care, large increases in training and eye care delivery systems development/financing are critical areas of focus.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Ophthalmic epidemiology
Ophthalmic epidemiology 医学-眼科学
CiteScore
3.70
自引率
5.60%
发文量
61
审稿时长
6-12 weeks
期刊介绍: Ophthalmic Epidemiology is dedicated to the publication of original research into eye and vision health in the fields of epidemiology, public health and the prevention of blindness. Ophthalmic Epidemiology publishes editorials, original research reports, systematic reviews and meta-analysis articles, brief communications and letters to the editor on all subjects related to ophthalmic epidemiology. A broad range of topics is suitable, such as: evaluating the risk of ocular diseases, general and specific study designs, screening program implementation and evaluation, eye health care access, delivery and outcomes, therapeutic efficacy or effectiveness, disease prognosis and quality of life, cost-benefit analysis, biostatistical theory and risk factor analysis. We are looking to expand our engagement with reports of international interest, including those regarding problems affecting developing countries, although reports from all over the world potentially are suitable. Clinical case reports, small case series (not enough for a cohort analysis) articles and animal research reports are not appropriate for this journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信